The Venture Codex Logo

The Venture Codex

Frontier Field

Minato-ku, Tokyo, Japan

Overview

Frontier Field develops and provides 日病モバイル, a secure smartphone service for hospitals that supports staff calls and communications. The service includes integration with nurse call systems and electronic medical records to streamline workflows. Launched in 2020 to accelerate DX for physicians and nurses, the product aims to replace shrinking PHS usage and address upcoming 2024 working-hours reforms. 日病モバイル is positioned as a hub to connect medical systems, devices, and personnel rather than merely a PHS replacement. The service is currently used by about 60 hospitals and more than 20,000 healthcare workers. The company recently completed a Series C that includes debt financing and will use the proceeds to improve the convenience and value of 日病モバイル. フロンティア・フィールド operates “日病モバイル”, a secure smartphone and DX service built for hospitals that connects carrier switches to the company’s system via IP‑VPN and dedicated lines to protect patient data. The platform offers hospital-specific integrations and apps — including nurse‑call and electronic medical record linkage, emergency alerting, and multi‑vendor SIP/VoIP support — to simplify multi‑professional coordination while reducing personal data leakage risk. It is designed to replace PHS, paper, and fax workflows and to enable direct data entry in home‑visit care, eliminating double data entry. The company has deployed 日病モバイル in 19 hospitals as of March 2022 and, with Japan Hospital Association cooperation, targets about 40 hospitals by December 2022 and 300 hospitals / 60,000 lines by the end of 2024. The service emphasizes a closed network model to address hospitals’ sensitivity about Internet connectivity and offers a common authentication basis for multiple applications. The company was founded in July 2016 by Yasuyuki Sato, a former NTT Docomo and Japan Altmark executive.

Total raised
$35M
Funding rounds
3
Latest round
Series C
Latest activity
Jul 2023

Industries

  • Artificial Intelligence (AI)
  • Big Data
  • Health Care
  • Medical
Visit website

Recent funding

  1. Series C

    Jul 2023

    $27M

  2. Series B

    Jun 2022

    $8M

Team

  • Yasuyuki Sato

    Representative Director / CEO / Founder